The global Imatinib Mesylate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Imatinib Mesylate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Imatinib Mesylate market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Imatinib Mesylate in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Imatinib Mesylate manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
GLEEVEC
Cayman Chemical
Sichuan Xieli
Nanjing Kaihua Chemical
Zhengda Tianqing
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
99% Purity
98% Purity
Other

Segment by Application
CML
GIST
Other